首页 > 最新文献

The Open Urology & Nephrology Journal最新文献

英文 中文
Acute Intermittent Peritoneal Dialysis in Critically Ill COVID-19 Patients with Renal Failure: Saviour or Succourer 急性间歇腹膜透析治疗重症COVID-19肾衰患者:救星还是救助者
Pub Date : 2022-05-31 DOI: 10.2174/1874303x-v15-e2203290
B. Varghese, Arul Rajagopalan, J. Arunachalam, A. Prasath, R. Durai
The COVID-19 pandemic has led to an increase in critically ill patients with renal failure, with many requiring renal replacement therapies. Unfortunately, many of them are too critically ill to tolerate intermittent hemodialysis. In the setting of limited resources, we did bedside acute intermittent peritoneal dialysis for critically ill COVID-19 patients with hemodynamic instability with or without ventilator support admitted to our intensive care unit. The aim of the study was to determine the outcome of intermittent peritoneal dialysis in critically ill COVID-19 patients. Our retrospective observational study included 91 patients with critically ill SARS-CoV2 infection and renal failure admitted to the intensive care unit of our hospital from July 2020 to September 2021, who underwent acute intermittent peritoneal dialysis. The demographic, laboratory, and treatment parameters were compared between survivors and non-survivors. Variables, like increased mean age (49.88 vs. 59.07 years), presence of diabetes mellitus (36.4% vs. 63.8%), increased lung involvement (57.3% vs. 75.0%), mechanical ventilation (15.2% vs. 70.7%), systolic (84.3 vs. 77.5 mm of Hg) and diastolic (59.09 vs. 42.93 mm of Hg) blood pressures, were associated with poor outcomes. The use of hypertonic PD (63.6% vs. 37.9%), better urea reduction ratios (44.33 vs. 39.84), and increased PD cycles (66.52 vs. 44.26) were associated with a better outcome. Complications, like haemorrhage and peritonitis, occurred in 10.9%. PD is a cost-effective bedside RRT that can be considered an effective option in critically ill COVID-19 patients. Good urea clearance, hemodynamic stability, and minimal resource requirements are also the features that favour peritoneal dialysis.
COVID-19大流行导致肾衰竭危重患者增加,其中许多人需要肾脏替代治疗。不幸的是,他们中的许多人病情严重,无法忍受间歇性血液透析。在资源有限的情况下,我们对重症监护室收治的血液动力学不稳定的COVID-19危重患者进行了床边急性间歇腹膜透析,无论是否有呼吸机支持。该研究的目的是确定重症COVID-19患者间歇腹膜透析的结果。我们的回顾性观察研究纳入了2020年7月至2021年9月在我院重症监护室接受急性间歇腹膜透析的91例重症SARS-CoV2感染并肾功能衰竭患者。比较幸存者和非幸存者的人口学、实验室和治疗参数。变量,如平均年龄增加(49.88比59.07岁),糖尿病的存在(36.4%比63.8%),肺受累增加(57.3%比75.0%),机械通气(15.2%比70.7%),收缩压(84.3比77.5毫米汞柱)和舒张压(59.09比42.93毫米汞柱),与不良预后相关。使用高渗PD (63.6% vs. 37.9%)、更好的尿素还原率(44.33 vs. 39.84)和增加PD周期(66.52 vs. 44.26)与更好的结果相关。并发症如出血和腹膜炎发生率为10.9%。PD是一种具有成本效益的床边RRT,可被认为是COVID-19危重患者的有效选择。良好的尿素清除率、血流动力学稳定性和最小的资源需求也是有利于腹膜透析的特点。
{"title":"Acute Intermittent Peritoneal Dialysis in Critically Ill COVID-19 Patients with Renal Failure: Saviour or Succourer","authors":"B. Varghese, Arul Rajagopalan, J. Arunachalam, A. Prasath, R. Durai","doi":"10.2174/1874303x-v15-e2203290","DOIUrl":"https://doi.org/10.2174/1874303x-v15-e2203290","url":null,"abstract":"\u0000 \u0000 The COVID-19 pandemic has led to an increase in critically ill patients with renal failure, with many requiring renal replacement therapies. Unfortunately, many of them are too critically ill to tolerate intermittent hemodialysis. In the setting of limited resources, we did bedside acute intermittent peritoneal dialysis for critically ill COVID-19 patients with hemodynamic instability with or without ventilator support admitted to our intensive care unit.\u0000 \u0000 \u0000 \u0000 The aim of the study was to determine the outcome of intermittent peritoneal dialysis in critically ill COVID-19 patients.\u0000 \u0000 \u0000 \u0000 Our retrospective observational study included 91 patients with critically ill SARS-CoV2 infection and renal failure admitted to the intensive care unit of our hospital from July 2020 to September 2021, who underwent acute intermittent peritoneal dialysis.\u0000 \u0000 \u0000 \u0000 The demographic, laboratory, and treatment parameters were compared between survivors and non-survivors. Variables, like increased mean age (49.88 vs. 59.07 years), presence of diabetes mellitus (36.4% vs. 63.8%), increased lung involvement (57.3% vs. 75.0%), mechanical ventilation (15.2% vs. 70.7%), systolic (84.3 vs. 77.5 mm of Hg) and diastolic (59.09 vs. 42.93 mm of Hg) blood pressures, were associated with poor outcomes. The use of hypertonic PD (63.6% vs. 37.9%), better urea reduction ratios (44.33 vs. 39.84), and increased PD cycles (66.52 vs. 44.26) were associated with a better outcome. Complications, like haemorrhage and peritonitis, occurred in 10.9%.\u0000 \u0000 \u0000 \u0000 PD is a cost-effective bedside RRT that can be considered an effective option in critically ill COVID-19 patients. Good urea clearance, hemodynamic stability, and minimal resource requirements are also the features that favour peritoneal dialysis.\u0000","PeriodicalId":213268,"journal":{"name":"The Open Urology & Nephrology Journal","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124855230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalent Practices in Male Anterior Urethral Stricture Management: A Survey 男性前尿道狭窄的常见治疗方法调查
Pub Date : 2022-04-27 DOI: 10.2174/1874303x-v15-e2203140
Suyog Shetty, S. Bhat, A. Choudhary, B. Hameed, Mummalaneni Sitaram, M. Shah, S. Reddy
This article aimed to study the prevalent practices in the treatment and follow-up of urethral strictures. Moreover, the article aimed to investigate the present opinion among urologists as the treatment practices for urethral stricture disease are mostly dependent on the treating surgeon’s expertise and preference in the absence of widely followed standard guidelines. A questionnaire was formulated based on the responses from experts. From October to December 2020, all members of the urological society of India received a mailed questionnaire on a web-based survey platform. Practicing urologists from across the country are among its members. A total of 2554 urologists were contacted by mail, and 282 (11%) urologists provided a response. The majority were doing 5 to 15 urethroplasties a year. A newly diagnosed short segment bulbar urethral stricture would be a candidate for a visualized internal urethrotomy (VIU), according to 69.5% of urologists. Recurrence after one attempt at VIU prompted 80% to switch to urethroplasty as the next choice. During preoperative evaluation, 100% of respondents wanted a retrograde urethrogram, 74% deemed micturating cystourethrogram necessary, and 60% wanted a urethroscopy. At discharge, the majority preferred silicone Foley catheters, and the preferred size was 16F (54%). The patients were discharged with both suprapubic catheter and Foley in situ by most urologists. During follow-up, 60.99% wanted uroflowmetry, and the duration of follow-up varied. This survey on urethral stricture management amongst urologists shows that there is wide variation in the management of stricture urethra. This survey underscores the need for large-scale, long-term studies to formulate a guideline for the management of urethral stricture disease, thereby bringing uniformity in the care provided.
本文旨在探讨尿道狭窄的治疗和随访的普遍做法。此外,本文旨在调查泌尿科医生目前的意见,因为尿道狭窄疾病的治疗方法主要取决于治疗外科医生的专业知识和偏好,而缺乏广泛遵循的标准指南。根据专家的回答,制定了一份调查问卷。从2020年10月到12月,印度泌尿学会的所有成员都在一个基于网络的调查平台上收到了一份邮寄的问卷。来自全国各地的执业泌尿科医生都是其成员。通过邮件联系了2554名泌尿科医生,其中282名(11%)泌尿科医生提供了回复。大多数人每年做5到15次尿道成形术。69.5%的泌尿科医生认为,新诊断的短段球尿道狭窄可考虑行可视化内尿道切开术。一次尝试后的复发促使80%的患者转向尿道成形术作为下一个选择。在术前评估中,100%的应答者希望行逆行尿道造影,74%的应答者认为有必要行尿囊尿道造影,60%的应答者希望行尿道镜检查。出院时,大多数患者首选硅胶Foley导管,首选尺寸为16F(54%)。大多数泌尿科医生出院时均保留耻骨上置管和原位置管。随访期间,60.99%的患者需要尿流测量,随访时间各不相同。泌尿科医师对尿道狭窄处理的调查显示,尿道狭窄的处理存在很大差异。这项调查强调需要进行大规模、长期的研究,以制定尿道狭窄疾病的治疗指南,从而使所提供的护理统一。
{"title":"Prevalent Practices in Male Anterior Urethral Stricture Management: A Survey","authors":"Suyog Shetty, S. Bhat, A. Choudhary, B. Hameed, Mummalaneni Sitaram, M. Shah, S. Reddy","doi":"10.2174/1874303x-v15-e2203140","DOIUrl":"https://doi.org/10.2174/1874303x-v15-e2203140","url":null,"abstract":"\u0000 \u0000 This article aimed to study the prevalent practices in the treatment and follow-up of urethral strictures. Moreover, the article aimed to investigate the present opinion among urologists as the treatment practices for urethral stricture disease are mostly dependent on the treating surgeon’s expertise and preference in the absence of widely followed standard guidelines.\u0000 \u0000 \u0000 \u0000 A questionnaire was formulated based on the responses from experts. From October to December 2020, all members of the urological society of India received a mailed questionnaire on a web-based survey platform. Practicing urologists from across the country are among its members.\u0000 \u0000 \u0000 \u0000 A total of 2554 urologists were contacted by mail, and 282 (11%) urologists provided a response. The majority were doing 5 to 15 urethroplasties a year. A newly diagnosed short segment bulbar urethral stricture would be a candidate for a visualized internal urethrotomy (VIU), according to 69.5% of urologists. Recurrence after one attempt at VIU prompted 80% to switch to urethroplasty as the next choice. During preoperative evaluation, 100% of respondents wanted a retrograde urethrogram, 74% deemed micturating cystourethrogram necessary, and 60% wanted a urethroscopy. At discharge, the majority preferred silicone Foley catheters, and the preferred size was 16F (54%). The patients were discharged with both suprapubic catheter and Foley in situ by most urologists. During follow-up, 60.99% wanted uroflowmetry, and the duration of follow-up varied.\u0000 \u0000 \u0000 \u0000 This survey on urethral stricture management amongst urologists shows that there is wide variation in the management of stricture urethra. This survey underscores the need for large-scale, long-term studies to formulate a guideline for the management of urethral stricture disease, thereby bringing uniformity in the care provided.\u0000","PeriodicalId":213268,"journal":{"name":"The Open Urology & Nephrology Journal","volume":"158 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125671618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Open Urology & Nephrology Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1